லிநேபேர்கேற் விரிவான புற்றுநோய் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from லிநேபேர்கேற் விரிவான புற்றுநோய். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In லிநேபேர்கேற் விரிவான புற்றுநோய் Today - Breaking & Trending Today

Not Seeing the Forest for the Trees: The Dangers of "Holding All Else Equal" | Harvard T.H. Chan School of Public Health


Fellow, Carolina Population Center
Member, Lineberger Comprehensive Cancer Center
This talk is an expansion of one that Dr. Robinson recorded for an upcoming SER 2021 symposium. That symposium is titled, “What has the pandemic revealed about the shortcomings of modern epidemiology? What can we fix or do better?” In that talk and here, she discusses two shortcomings she perceives in academic epidemiology’s response to the COVID-19 outbreak. One is an overreliance on conditional statistics and the other is workforce that is too homogenous with respect to the diversity of the US population. ....

Whitneyr Robinson , Gillings School Of Global Public Health , Lineberger Comprehensive Cancer Center , Carolina Population Center , Department Of Epidemiology Seminar Series , Epidemiology Seminar , Global Public , Carolina Population , Lineberger Comprehensive Cancer , லிநேபேர்கேற் விரிவான புற்றுநோய் மையம் , கரோலினா பாப்யுலேஶந் மையம் , துறை ஆஃப் தொற்றுநோய் கருத்தரங்கு தொடர் , தொற்றுநோய் கருத்தரங்கு , உலகளாவிய பொது , கரோலினா பாப்யுலேஶந் , லிநேபேர்கேற் விரிவான புற்றுநோய் ,

Study: Modified immunotherapy may work in advanced breast cancer


Study: Modified immunotherapy may work in advanced breast cancer
By
(0)
Researchers say they have found a potential new treatment approach for breast cancer using immunotherapy. File Photo by uschenkova/Shutterstock
Dec. 31 (UPI) Women with advanced breast cancer may have a new weapon in their fight against the disease a modified form of immunotherapy.
CAR-T immunotherapy, in which T cells from a patient s immune system are modified to target cancer cells, has been most effective in the treatment of B-cell leukemia or lymphoma, both of which are cell-based, rather than solid-tumor cancers like breast cancer.
Advertisement
Adding a molecule found in immune cells called cGAMP to standard CAR-T boosts its efficacy in breast cancer by encouraging the body s immune cells to attack solid tumors, according to the authors of a study published Thursday by the Journal of Experimental Medicine. ....

United States , Jonathans Serody , American Cancer Society , North Carolina , Lineberger Comprehensive Cancer , American Cancer , ஒன்றுபட்டது மாநிலங்களில் , அமெரிக்கன் புற்றுநோய் சமூகம் , வடக்கு கரோலினா , லிநேபேர்கேற் விரிவான புற்றுநோய் , அமெரிக்கன் புற்றுநோய் ,